Abcellera Biologics Inc (ABCL) revenue is $28.8M
Abcellera Biologics Inc (ABCL) revenue is $28.8M as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full ABCL research page for quote, filings, and the rest of the model. This satellite exists so “Abcellera Biologics Inc revenue” can rank with the actual number, then send you to /stock/abcl.